Results 101 to 110 of about 160,899 (200)

Antitumor activity of neurokinin-1 receptor antagonists in MG-63 human osteosarcoma xenografts.

International Journal of Oncology, 2014
M. Muñoz, M. Berger, M. Rosso, A. González-Ortega, A. Carranza, R. Coveñas   +5 more
semanticscholar   +1 more source

Neurokinin-1 receptor antagonists for chemotherapy-induced nausea and vomiting: a systematic review.

Journal of the National Cancer Institute, 2012
L. D. dos Santos, F. Souza, A. Brunetto, A. Sasse, João Paulo da Silveira Nogueira Lima   +4 more
semanticscholar   +1 more source

Possible Mechanism of Action of Neurokinin-1 Receptors (NK1R) Antagonists [PDF]

Journal of Pharmacy and Pharmacology, 2017
null Özüm Öztürk, null Esin Aki-Yalcin, null Tugba Ertan-Bolelli, null Kayhan Bolelli, null Andry Nur-Hidayat, null Ozlem Bingol-Ozakpinar, null Filiz Ozdemir, null Ismail Yalcin   +7 more
openaire   +1 more source

Design and synthesis of a novel, achiral class of highly potent and selective, orally active neurokinin-1 receptor antagonists.

Bioorganic & Medicinal Chemistry Letters, 2006
T. Hoffmann, M. Bös, H. Stadler, P. Schnider, W. Hunkeler, T. Godel, G. Galley, T. Ballard, G. Higgins, S. Poli, A. Sleight   +10 more
semanticscholar   +1 more source

Potential risk of neoplasms with fezolinetant: clinical evidence, mechanisms, and post-marketing implications. [PDF]

J Endocr Soc
Boretti E, Dogné JM, Douxfils J.
europepmc   +1 more source

Elinzanetant: Defining the Role of Dual Neurokinin-1 and Neurokinin-3 Receptor Antagonism for Management of Vasomotor Symptoms in Menopause. [PDF]

J Menopausal Med
Teli V, Teli A.
europepmc   +1 more source

Moving beyond promethazine: Advancing precision in antiemetic therapy. [PDF]

SAGE Open Med
Ryan MF, Lagasse C.
europepmc   +1 more source

Targeting Peptidergic Systems for Melanoma Treatment. [PDF]

Cancers (Basel)
Sánchez ML, Mehboob R, Coveñas R.
europepmc   +1 more source

Olanzapine Use and Vomiting Incidence in Chemotherapy-receiving Patients With Cervical Cancer: Multicenter Post Hoc Analysis. [PDF]

In Vivo
Kawamura Y, Yoshida K, Morita H, Nakai M, Matsumoto T, Gohara Y, Hoshino N, Tonomura N, Banba M, Yamaguchi A, Tachibana M, Fukushima T, Hosokawa H, Mura T, Yabuki T, Watanabe S, Watanabe A, Sugiura M.   +17 more
europepmc   +1 more source

Efficacy of steroid-omitting antiemetic therapy in patients with advanced pancreatic cancer receiving nano-liposomal irinotecan plus fluorouracil and leucovorin. [PDF]

Support Care Cancer
Tokito Y, Ishigaki K, Nara K, Endo G, Nishio H, Fukuda K, Suzuki T, Sato Y, Takahara N, Boku N, Fujishiro M.   +10 more
europepmc   +1 more source